13 min reading time

Treating SIBO With Probiotics

Small intestinal bacterial overgrowth, commonly known as SIBO, happens when too many bacteria build up in the small intestine. Because the condition involves an excess of bacteria, using probiotics to treat it often confuses patients. Probiotics are live microorganisms that offer health benefits when a person consumes them in adequate amounts¹. Taking supplements filled with bacteria to treat a bacterial overgrowth seems counterproductive.
However, the scientific understanding of probiotics shows that they do not simply add to the crowding in the small intestine. Instead, specific probiotic strains act as temporary visitors that alter the environment of the digestive tract. Probiotics compete directly with the harmful bacteria for food and physical space along the intestinal walls¹. They also produce natural antimicrobial substances and organic acids that lower the pH of the gut, making the small intestine an unwelcoming place for the overgrowing bacteria¹. Furthermore, probiotics stimulate the local immune system and prevent harmful bacteria from sticking to the mucosal lining¹. Because of these specific actions, doctors and researchers use carefully selected probiotic strains to help clear the overgrowth and manage the symptoms of SIBO.

Overall Effectiveness of Probiotic Treatment

Researchers use clinical trials and large data reviews, called meta-analyses, to understand exactly how well probiotics work for SIBO. The combined results show a complex picture. Several studies indicate that probiotic supplements effectively decontaminate the small intestine, reduce the concentration of hydrogen gas, and relieve abdominal pain⁶. When researchers measure the decontamination rate, which is the percentage of people who clear the overgrowth entirely, they find that patients taking probiotics have a success rate of 62.8%⁶. This rate is significantly higher than the success rate for patients who receive no treatment or a placebo⁶.
Despite these positive numbers, the medical community notes that the evidence is sometimes inconsistent. Some meta-analyses classify the clinical evidence supporting probiotics for SIBO as low-quality due to a high risk of bias in the available studies⁷. Other studies report that probiotics do not offer a significant benefit over a placebo in treating the condition⁸. Furthermore, while probiotics help treat an active overgrowth, data shows they are completely ineffective at preventing SIBO from developing in the first place⁶. Because of these mixed results, medical professionals emphasize that probiotics are not a universal cure. They must be selected carefully based on the patient’s specific symptoms and the exact strain of the microorganism.

The Risk of Brain Fog and D-Lactic Acidosis

While probiotics help many people, they cause severe adverse reactions in a specific group of SIBO patients. A major clinical study conducted by Dr. Satish Rao and his team at the Medical College of Georgia identified a direct connection between probiotic use, SIBO, and a condition called D-lactic acidosis¹⁰. Patients in this group experienced severe abdominal bloating, gas, and a neurological symptom described as brain fog. Brain fog involves mental confusion, impaired judgment, poor short-term memory, and difficulty concentrating¹⁰.
The problem begins when patients consume probiotics containing certain bacteria, particularly strains of Lactobacillus and Bifidobacterium. These bacteria have a unique capacity to break down dietary sugars and ferment them rapidly¹⁰. In a normal digestive system, probiotics move through the small intestine and settle in the large intestine. In patients with delayed digestion or motility issues, the probiotic bacteria remain in the small intestine and colonize it, setting the stage for an overgrowth¹¹.
When these patients eat food, the bacteria go into a feeding frenzy and ferment the carbohydrates. This rapid fermentation produces large amounts of hydrogen and methane gas, which causes severe bloating¹⁰. During this process, the bacteria also produce a specific type of acid called D-lactic acid¹⁰. The human body processes regular L-lactic acid easily, but it lacks the necessary enzymes to metabolize D-lactic acid quickly¹⁴. As the bacteria produce massive amounts of D-lactic acid in the small intestine, the acid absorbs into the bloodstream¹⁰.
Once in the blood, the D-lactic acid travels to the brain. D-lactic acid is temporarily toxic to brain cells¹¹. It interferes with cognition, thinking, and the sense of time, creating the disorientation known as brain fog¹¹. Researchers found that some SIBO patients taking probiotics had two to three times the normal amount of D-lactic acid in their blood¹⁰.
The treatment for this specific complication is straightforward. Doctors advise patients to stop taking all probiotics, including food sources like yogurt, and prescribe a course of antibiotics to kill the bacterial overgrowth¹¹. Following this treatment protocol, 85% of patients in Dr. Rao’s study reported that their brain fog disappeared entirely, and 70% experienced significant improvement in their bloating and gas¹¹. This evidence leads researchers to warn that probiotics act more like targeted drugs rather than casual food supplements¹⁰.

Combining Probiotics With Antibiotic Therapy

Standard medical treatment for SIBO relies heavily on antibiotics. Rifaximin is the most common antibiotic used because it stays within the digestive tract, acting locally rather than absorbing into the general bloodstream¹⁶. While rifaximin is highly effective on its own, researchers find that combining it with probiotics yields even better results.
Clinical trials show that patients receiving a combination of rifaximin and probiotics experience a greater reduction in their symptoms than those taking the antibiotic alone¹⁶. In one study, patients took rifaximin for a week, followed immediately by a week of a Lactobacillus casei probiotic supplement. This combination approach improved diffuse abdominal pain, left iliac pain, bloating, flatulence, and nausea¹⁹. The sequential treatment method, where the patient finishes the antibiotic and immediately begins the probiotic, replenishes the gut with helpful bacteria before harmful bacteria have a chance to return and cause a relapse¹⁹.

Yeast-Based Probiotics

Most probiotics contain live bacteria. However, Saccharomyces boulardii is a different type of probiotic. It is a live, beneficial yeast²¹. Because it is a fungus and not a bacterium, it offers unique advantages for treating SIBO.
First, adding a yeast to the digestive tract does not increase the bacterial count in the small intestine²³. Second, traditional antibacterial drugs do not kill yeast. This means patients can take Saccharomyces boulardii at the exact same time as their antibiotic prescription without the antibiotic destroying the probiotic²³.
A specific strain known as Saccharomyces boulardii CNCM I-745 shows high effectiveness in SIBO treatment. In a clinical trial involving patients who developed SIBO after long-term use of stomach acid-reducing medications (proton pump inhibitors), researchers compared two groups. One group took only rifaximin, and the other group took rifaximin alongside Saccharomyces boulardii CNCM I-745²³. After four weeks, the overgrowth persisted in 41.5% of the patients who only took the antibiotic. In the group that took the yeast combination, the overgrowth persisted in only 21.8% of patients²³. The yeast combination also provided a statistically significant resolution of diarrhea and improved the overall quality of life for the patients²³.
This yeast strain is also highly effective for SIBO patients who have liver cirrhosis. In a study of cirrhosis patients, three months of treatment with Saccharomyces boulardii eliminated SIBO in 80% of the patients, compared to only 23.1% in the placebo group²². The treatment also decreased the incidence of severe liver complications, such as fluid buildup in the abdomen (ascites) and brain dysfunction caused by liver disease (hepatic encephalopathy)²².

Spore-Forming Probiotics

The stomach contains highly acidic fluids designed to break down food and kill incoming microbes. Many standard probiotic bacteria die in the stomach before they ever reach the small intestine. Spore-forming probiotics bypass this problem. Bacteria in the Bacillus family form a hard, protective outer shell called a spore²⁵. This spore allows the bacteria to survive extreme heat, high stomach acid levels, and bile salts². Once the spore safely passes through the stomach and enters the more neutral environment of the small intestine, the bacteria germinate and become active².

Bacillus clausii

Bacillus clausii is a well-researched spore-forming probiotic. It possesses a natural, broad-spectrum resistance to many commonly used antibiotics, making it safe to take simultaneously during antibiotic therapy³. Once active in the gut, Bacillus clausii secretes antimicrobial substances, such as a compound called clausin, which actively attacks and inhibits the growth of harmful bacteria³. It also helps enhance the physical function of the intestinal barrier²⁵.
In a clinical trial testing Bacillus clausii as a standalone treatment for SIBO, patients took the probiotic three times a day for one month³. At the end of the study, 47% of the patients had a completely normal follow-up breath test, indicating the overgrowth was gone³. This normalization rate is comparable to the success rates of many standard antibiotic treatments³. The treatment was also exceptionally safe, with only one patient reporting a minor side effect of constipation³. Bacillus clausii is also highly effective at reducing the duration and severity of diarrhea, particularly diarrhea caused by antibiotic use or gastrointestinal infections²⁸.

Bacillus coagulans

Bacillus coagulans is another spore-forming bacterium that exhibits characteristics of both the Bacillus and Lactobacillus families³¹. It produces lactic acid and secretes digestive enzymes³¹. Once it germinates in the small intestine, it aids in the direct digestion of carbohydrates and proteins, which helps prevent those nutrients from fermenting and causing gas².
Specific strains of this bacterium provide targeted relief for SIBO-related symptoms. The strain Bacillus coagulans MTCC 5856 was tested in adults suffering from functional gas and bloating. After four weeks of supplementation, the patients experienced significant improvements in indigestion, stomach rumbling, and gas³². Another strain, Bacillus coagulans GBI-30, 6086, reduces the average number of daily bowel movements in patients with diarrhea and decreases abdominal pain².

Probiotics for Methane-Dominant SIBO

SIBO is categorized by the type of gas produced by the organisms in the gut. While many bacteria produce hydrogen gas, a different type of single-celled organism called an archaeon produces methane gas²¹. The specific organism responsible for this is usually Methanobrevibacter smithii³⁶. Because it involves archaea rather than bacteria, the medical community frequently refers to methane-dominant SIBO as Intestinal Methanogen Overgrowth, or IMO³⁶. Methane gas actively slows down the physical movement of the intestines. Because the intestines move too slowly, patients with methane-dominant SIBO almost always suffer from chronic constipation³⁶.
Lactobacillus reuteri, specifically the strain DSM 17938, is highly effective at managing methane production. Researchers observed patients with chronic constipation and high methane levels who took Lactobacillus reuteri DSM 17938 for four weeks³⁸. The probiotic treatment caused a massive and significant decrease in methane gas production. In 11 out of the 20 patients, the methane production disappeared completely, falling below the detectable threshold on a breath test³⁸. By reducing the methane gas, the intestines resumed normal movement, which significantly improved the patients’ bowel movements and relieved their chronic constipation⁵.

Managing Gas and Bloating With Specific Strains

Abdominal bloating is one of the most common and bothersome symptoms for patients with SIBO³⁹. The bloating occurs because the excess bacteria ferment dietary carbohydrates, creating large volumes of trapped gas that physically stretch the intestinal walls³⁹.
Lactobacillus plantarum, specifically the strain 299v, is heavily researched for its ability to reduce these specific symptoms. This strain has a strong ability to colonize the intestinal mucosa when taken orally⁴¹. Clinical trials show that patients taking Lactobacillus plantarum 299v experience a significant decrease in the frequency and severity of abdominal pain episodes³⁹. The probiotic also normalizes stool consistency and reduces the feeling of incomplete rectal emptying⁴¹. By modulating the gut microflora and reducing the fermentation of unabsorbed carbohydrates, this strain lessens the physical distention of the abdomen⁴².

Multi-Strain Blends and Breath Test Interference

Some probiotic supplements combine many different strains into a single, high-dose formula. VSL#3, also known by the generic name De Simone Formulation, is a well-known multi-strain probiotic that contains a mixture of Lactobacillus species, Bifidobacterium species, and Streptococcus thermophilus⁴⁴. Studies on multi-strain blends show mixed results for SIBO. Some clinical trials show that high doses of VSL#3 eliminate SIBO in roughly 58% of cases⁴⁵. Other studies indicate that while it significantly reduces abdominal bloating, it does not reliably improve other parameters like colon transit time or flatulence⁴⁴.
Patients must be careful when using certain strains of Bifidobacterium before diagnostic testing. SIBO is diagnosed using a breath test, which measures the levels of hydrogen and methane gas exhaled after drinking a sugar solution²¹. A study analyzing the probiotic strain Bifidobacterium infantis 35624 found that taking this supplement alters the results of the breath test⁴⁷.
Healthy subjects who took Bifidobacterium infantis 35624 for two weeks showed significantly higher levels of methane gas excretion during their breath tests⁴⁷. The methane levels reached numbers that are traditionally considered positive for SIBO, even though the subjects were healthy and had no bacterial overgrowth⁴⁷. The probiotic did not change hydrogen levels, but the artificial spike in methane creates a high risk of a false-positive diagnosis⁴⁷. Because probiotics interfere with the accuracy of the gas readings, medical professionals recommend that patients completely discontinue all probiotic use prior to undergoing a diagnostic breath test⁴⁷.

The Synergy of Prebiotics and Postbiotics

Probiotics are living organisms, and they require food to survive and function. Prebiotics are specialized types of dietary fiber that the human body cannot digest. Instead, they pass into the digestive tract and serve as a food source for the beneficial probiotic bacteria⁴⁹.
Partially hydrolyzed guar gum, or PHGG, is a water-soluble prebiotic fiber. Unlike many other fibers that ferment rapidly and cause explosive gas and bloating, PHGG ferments very slowly in the intestines¹⁷. This slow fermentation makes it highly tolerable for SIBO patients¹⁷.
Clinical research demonstrates that combining PHGG with antibiotics drastically improves SIBO treatment. In a major clinical trial, patients with SIBO were divided into two groups. One group received 1200 mg of the antibiotic rifaximin daily. The second group received the exact same dose of rifaximin, plus 5 grams of PHGG daily⁵².
The eradication rate for the patients taking only the antibiotic was 62.1%⁵². However, the eradication rate for the patients taking the antibiotic alongside the PHGG prebiotic jumped to 87.1%⁵². Researchers attribute this massive increase in effectiveness to the prebiotic fiber feeding the beneficial bacteria, which in turn helps regulate intestinal motility and clear the overgrowth¹⁷.
When probiotic bacteria consume prebiotics like PHGG, they produce metabolic byproducts. These byproducts are known as postbiotics⁵⁰. Postbiotics consist of inanimate microbial components and specific chemical compounds that directly benefit the human host⁵⁰.
The most important postbiotics produced in the gut are short-chain fatty acids, specifically butyrate, acetate, and propionate⁴. Butyrate is the primary energy source for the cells that line the colon⁵⁵. It plays a critical role in repairing the intestinal mucosa, which is often damaged and inflamed by the bacterial overgrowth⁵⁴.
Butyrate strengthens the epithelial defense barrier, preventing harmful bacterial toxins from leaking out of the intestines and into the bloodstream⁵⁰. It also regulates the absorption of fluids and electrolytes, which stops chronic diarrhea⁵⁵. Acetate and propionate contribute to lowering the pH of the intestines, creating a slightly acidic environment that actively prevents pathogenic and overgrowing bacteria from surviving⁴. By focusing on providing prebiotics to generate these postbiotics, patients heal the structural damage caused by SIBO and restore normal digestive function.

Summary of Probiotic Strains for SIBO Treatment

The table below summarizes the specific probiotic strains, their physical classifications, and their primary therapeutic effects on SIBO based on clinical research.

Probiotic Strain	Type / Classification	Primary Target in SIBO Treatment	Documented Clinical Effects
Saccharomyces boulardii CNCM I-745	Beneficial Yeast	Co-administration with antibiotics	Eradicates SIBO at higher rates than antibiotics alone; immune to antibacterial drugs; stops diarrhea²².
Bacillus clausii	Spore-forming Bacteria	Standalone decontamination	Survives stomach acid; secretes antimicrobial compounds; normalizes breath tests at rates comparable to antibiotics³.
Bacillus coagulans (GBI-30, 6086 / MTCC 5856)	Spore-forming Bacteria	Gas, bloating, and digestion	Aids protein and carbohydrate digestion; significantly reduces abdominal pain, gas, and daily bowel movements².
Lactobacillus reuteri DSM 17938	Lactic Acid Bacteria	Methane SIBO (IMO)	Drastically reduces methane gas production; improves intestinal motility; relieves chronic constipation⁵.
Lactobacillus plantarum 299v	Lactic Acid Bacteria	Abdominal pain and distension	Colonizes mucosa; reduces pain severity; normalizes stool consistency; limits gas production⁴¹.
Bifidobacterium infantis 35624	Lactic Acid Bacteria	General IBS symptom relief	Reduces general symptoms but increases methane excretion on breath tests, creating a risk for false-positive diagnoses⁴⁷.

Works Cited & Scientific References 58

▼

Topics & Tags: